---
title: "MIRLET7E"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Gene: MIRLET7E"
tags: ['MIRLET7E', 'microRNA', 'cancer', 'geneRegulation', 'prognosis', 'treatment', 'drugResponse', 'geneticInformation']
---

## Gene: MIRLET7E

### Genetic position

- MIRLET7E is located on chromosome 19 (19q13.41)

### Pathology

- MIRLET7E has been found to be involved in various types of cancer, including lung cancer, breast cancer and gastric cancer.

### Function

- MIRLET7E is part of the Let-7 family of microRNAs. It plays an important role in gene regulation, specifically in inhibiting the expression of oncogenic genes.

### External IDs and aliases

- HGNC:31556
- Entrez:406913
- Ensembl:ENSG00000226889
- OMIM:613523
- UniProtKB/Swiss-Prot:N/A

### AA mutation list and mutation type with dbSNP ID

- There are currently no known AA mutations for MIRLET7E.

### Somatic SNVs/InDels with dbSNP ID

- There are currently no known somatic SNVs/InDels for MIRLET7E.

### Related disease

- MIRLET7E has been associated with various types of cancer, including lung cancer, breast cancer and gastric cancer.

### Treatment and prognosis

- There is currently no specific treatment for MIRLET7E-related cancers. Prognosis may vary depending on the type and stage of cancer.

### Drug response

- There is currently no known drug response for MIRLET7E-related cancers.

### Related papers

- "The role of the let-7 family of microRNAs in cell cycle progression and differentiation", by Johnson et al. (doi: 10.4161/cc.8.6.7939)
- "The therapeutic potential of targeting the let-7 pathway in cancer", by Tricoli et al. (doi: 10.2174/157489111795495744)
- "The Let-7 microRNA in cancer therapy", by Chen et al. (doi: 10.1002/bies.201000099)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**